{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:41:55Z","timestamp":1788579715830,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Characteristic cerebral pathological changes of Alzheimer\u2019s disease (AD) such as glucose hypometabolism or the accumulation of cleavage products of the amyloid precursor protein (APP), known as A\u03b2 peptides, lead to sustained endoplasmic reticulum (ER) stress and neurodegeneration. To preserve ER homeostasis, cells activate their unfolded protein response (UPR). The rhomboid-like-protease 4 (RHBDL4) is an enzyme that participates in the UPR by targeting proteins for proteasomal degradation. We demonstrated previously that RHBDL4 cleaves APP in HEK293T cells, leading to decreased total APP and A\u03b2. More recently, we showed that RHBDL4 processes APP in mouse primary mixed cortical cultures as well. Here, we aim to examine the physiological relevance of RHBDL4 in the brain. We first found that brain samples from AD patients and an AD mouse model (APPtg) showed increased RHBDL4 mRNA and protein expression. To determine the effects of RHBDL4\u2019s absence on APP physiology in vivo, we crossed APPtg mice to a RHBDL4 knockout (R4\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    ) model. RHBDL4 deficiency in APPtg mice led to increased total cerebral APP and amyloidogenic processing when compared to APPtg controls. Contrary to expectations, as assessed by cognitive tests, RHBDL4 absence rescued cognition in 5-month-old female APPtg mice. Informed by unbiased RNA-seq data, we demonstrated in vitro and in vivo that RHBDL4 absence leads to greater levels of active \u03b2-catenin due to decreased proteasomal clearance. Decreased \u03b2-catenin activity is known to underlie cognitive defects in APPtg mice and AD. Our work suggests that RHBDL4\u2019s increased expression in AD, in addition to regulating APP levels, leads to aberrant degradation of \u03b2-catenin, contributing to cognitive impairment.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07579-z","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T06:45:18Z","timestamp":1744440318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer\u2019s disease mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"Ylauna Christine M\u00e9gane","family":"Penalva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Paschkowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherilyn Junelle","family":"Recinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Cinkornpumin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ruelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Nitu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Yee-Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Markus","family":"Munter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6815-0529","authenticated-orcid":false,"given":"Margaret","family":"Fahnestock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4176-5299","authenticated-orcid":false,"given":"William A.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5736-1462","authenticated-orcid":false,"given":"Lisa Marie","family":"Munter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"7579_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","volume":"9","author":"D Krstic","year":"2013","unstructured":"Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2013;9:25\u201334.","journal-title":"Nat Rev Neurol"},{"key":"7579_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"GD Collaborators","year":"2019","unstructured":"Collaborators GD. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:88\u2013106.","journal-title":"Lancet Neurol"},{"key":"7579_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11:111\u201328.","journal-title":"Dialogues Clin Neurosci"},{"key":"7579_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings JL, Morstorf T, Zhong K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6:37.","journal-title":"Alzheimers Res Ther"},{"key":"7579_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2022","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 Phase 3 studies evaluating Aducanumab in patients with early Alzheimer Disease. JAMA Neurol. 2022;79:13\u201321.","journal-title":"JAMA Neurol"},{"key":"7579_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JAD-190764","volume":"73","author":"JT He","year":"2020","unstructured":"He JT, Zhao X, Xu L, Mao CY. Vascular risk factors and Alzheimer\u2019s disease: blood-brain barrier disruption, metabolic syndromes, and molecular links. J Alzheimers Dis. 2020;73:39\u201358.","journal-title":"J Alzheimers Dis"},{"key":"7579_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11934","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-P\u00e9rez JM, Evans AC. Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun. 2016;7:11934.","journal-title":"Nat Commun"},{"key":"7579_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","volume":"14","author":"Y An","year":"2018","unstructured":"An Y, Varma VR, Varma S, Casanova R, Dammer E, Pletnikova O, et al. Evidence for brain glucose dysregulation in Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:318\u201329.","journal-title":"Alzheimers Dement"},{"key":"7579_CR9","doi-asserted-by":"crossref","unstructured":"Kumar V, Kim SH, Bishayee K. Dysfunctional glucose metabolism in Alzheimer\u2019s disease onset and potential pharmacological interventions. Int J Mol Sci. 2022;23:9540.","DOI":"10.3390\/ijms23179540"},{"key":"7579_CR10","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","volume":"261","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem. 1986;261:6084\u20139.","journal-title":"J Biol Chem"},{"key":"7579_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener. 2020;15:40.","journal-title":"Mol Neurodegener"},{"key":"7579_CR12","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7579_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","volume":"12","author":"GK Gouras","year":"2015","unstructured":"Gouras GK, Olsson TT, Hansson O. \u03b2-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease. Neurotherapeutics. 2015;12:3\u201311.","journal-title":"Neurotherapeutics"},{"key":"7579_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, Walter J, Saido TC, F\u00e4ndrich M. Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer\u2019s disease. Acta Neuropathol. 2015;129:167\u201382.","journal-title":"Acta Neuropathol"},{"key":"7579_CR15","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2012;2:a006270.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"7579_CR16","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017;14:e1002270.","journal-title":"PLoS Med"},{"key":"7579_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40478-023-01577-y","volume":"11","author":"S Schilling","year":"2023","unstructured":"Schilling S, Pradhan A, Heesch A, Helbig A, Blennow K, Koch C, et al. Differential effects of familial Alzheimer\u2019s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity. Acta Neuropathol Commun. 2023;11:87.","journal-title":"Acta Neuropathol Commun"},{"key":"7579_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC M\u00fcller","year":"2017","unstructured":"M\u00fcller UC, Deller T, Korte M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017;18:281\u201398.","journal-title":"Nat Rev Neurosci"},{"key":"7579_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000094772","volume":"3","author":"Y Senechal","year":"2006","unstructured":"Senechal Y, Larmet Y, Dev KK. Unraveling in vivo functions of amyloid precursor protein: insights from knockout and knockdown studies. Neurodegener Dis. 2006;3:134\u201347.","journal-title":"Neurodegener Dis"},{"key":"7579_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/glia.23561","volume":"67","author":"PH Truong","year":"2019","unstructured":"Truong PH, Ciccotosto GD, Merson TD, Spoerri L, Chuei MJ, Ayers M, et al. Amyloid precursor protein and amyloid precursor-like protein 2 have distinct roles in modulating myelination, demyelination, and remyelination of axons. Glia. 2019;67:525\u201338.","journal-title":"Glia"},{"key":"7579_CR21","doi-asserted-by":"publisher","first-page":"21903","DOI":"10.1074\/jbc.M116.753582","volume":"291","author":"S Paschkowsky","year":"2016","unstructured":"Paschkowsky S, Hamz\u00e9 M, Oestereich F, Munter LM. Alternative processing of the amyloid precursor protein family by rhomboid protease RHBDL4. J Biol Chem. 2016;291:21903\u201312.","journal-title":"J Biol Chem"},{"key":"7579_CR22","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1515\/hsz-2018-0259","volume":"399","author":"SJ Recinto","year":"2018","unstructured":"Recinto SJ, Paschkowsky S, Munter LM. An alternative processing pathway of APP reveals two distinct cleavage modes for rhomboid protease RHBDL4. Biol Chem. 2018;399:1399\u2013408.","journal-title":"Biol Chem"},{"key":"7579_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107541","volume":"300","author":"YCM Penalva","year":"2024","unstructured":"Penalva YCM, Paschkowsky S, Recinto SJ, Duchesne A, Hammond T, Spiegler P, et al. Eta-secretase-like processing of the amyloid precursor protein (APP) by the rhomboid protease RHBDL4. J Biol Chem. 2024;300:107541.","journal-title":"J Biol Chem"},{"key":"7579_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature14864","volume":"526","author":"M Willem","year":"2015","unstructured":"Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, et al. \u03b7-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature. 2015;526:443\u20137.","journal-title":"Nature"},{"key":"7579_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.molcel.2012.06.008","volume":"47","author":"L Fleig","year":"2012","unstructured":"Fleig L, Bergbold N, Sahasrabudhe P, Geiger B, Kaltak L, Lemberg MK. Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins. Mol Cell. 2012;47:558\u201369.","journal-title":"Mol Cell"},{"key":"7579_CR26","doi-asserted-by":"crossref","unstructured":"Knopf JD, Landscheidt N, Pegg CL, Schulz BL, K\u00fchnle N, Chao CW, et al. Intramembrane protease RHBDL4 cleaves oligosaccharyltransferase subunits to target them for ER-associated degradation. J Cell Sci. 2020;133:jcs243790.","DOI":"10.1242\/jcs.243790"},{"key":"7579_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s12276-021-00560-8","volume":"53","author":"KR Bhattarai","year":"2021","unstructured":"Bhattarai KR, Riaz TA, Kim HR, Chae HJ. The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling. Exp Mol Med. 2021;53:151\u201367.","journal-title":"Exp Mol Med"},{"key":"7579_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111175","volume":"40","author":"J Bock","year":"2022","unstructured":"Bock J, K\u00fchnle N, Knopf JD, Landscheidt N, Lee JG, Ye Y, et al. Rhomboid protease RHBDL4 promotes retrotranslocation of aggregation-prone proteins for degradation. Cell Rep. 2022;40:111175.","journal-title":"Cell Rep"},{"key":"7579_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1021\/acs.biochem.2c00680","volume":"62","author":"JM Hsiao","year":"2023","unstructured":"Hsiao JM, Penalva YCM, Wu HY, Xiao B, Jansen G, Dejgaard K, et al. Putative protein interactome of the rhomboid protease RHBDL4. Biochemistry. 2023;62:1209\u201318.","journal-title":"Biochemistry"},{"key":"7579_CR30","doi-asserted-by":"publisher","first-page":"101935","DOI":"10.1016\/j.jbc.2022.101935","volume":"298","author":"VL Lastun","year":"2022","unstructured":"Lastun VL, Levet C, Freeman M. The mammalian rhomboid protein RHBDL4 protects against endoplasmic reticulum stress by regulating the morphology and distribution of ER sheets. J Biol Chem. 2022;298:101935.","journal-title":"J Biol Chem"},{"key":"7579_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-022-04414-9","volume":"602","author":"S Tang","year":"2022","unstructured":"Tang S, Beattie AT, Kafkova L, Petris G, Huguenin-Dezot N, Fiedler M, et al. Mechanism-based traps enable protease and hydrolase substrate discovery. Nature. 2022;602:701\u20137.","journal-title":"Nature"},{"key":"7579_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05153-5","volume":"13","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady A, Lindholm D, Ren J, Pratico D. ER stress and UPR in Alzheimer\u2019s disease: mechanisms, pathogenesis, treatments. Cell Death Dis. 2022;13:706.","journal-title":"Cell Death Dis"},{"key":"7579_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000334536","volume":"10","author":"JJ Hoozemans","year":"2012","unstructured":"Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W. Activation of the unfolded protein response is an early event in Alzheimer\u2019s and Parkinson\u2019s disease. Neurodegener Dis. 2012;10:212\u20135.","journal-title":"Neurodegener Dis"},{"key":"7579_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8:1\u201313.","journal-title":"Alzheimers Dement"},{"key":"7579_CR35","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000;20:4050\u20138.","journal-title":"J Neurosci"},{"key":"7579_CR36","doi-asserted-by":"publisher","first-page":"e59586","DOI":"10.1371\/journal.pone.0059586","volume":"8","author":"AL Wright","year":"2013","unstructured":"Wright AL, Zinn R, Hohensinn B, Konen LM, Beynon SB, Tan RP, et al. Neuroinflammation and neuronal loss precede A\u03b2 plaque deposition in the hAPP-J20 mouse model of Alzheimer\u2019s disease. PLoS ONE. 2013;8:e59586.","journal-title":"PLoS ONE"},{"key":"7579_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2042-6410-3-24","volume":"3","author":"DB Dubal","year":"2012","unstructured":"Dubal DB, Broestl L, Worden K. Sex and gonadal hormones in mouse models of Alzheimer\u2019s disease: what is relevant to the human condition?. Biol Sex Differ. 2012;3:24.","journal-title":"Biol Sex Differ"},{"key":"7579_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/156720511794604561","volume":"8","author":"MT Ferretti","year":"2011","unstructured":"Ferretti MT, Partridge V, Leon WC, Canneva F, Allard S, Arvanitis DN, et al. Transgenic mice as a model of pre-clinical Alzheimer\u2019s disease. Curr Alzheimer Res. 2011;8:4\u201323.","journal-title":"Curr Alzheimer Res"},{"key":"7579_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3.","journal-title":"Signal Transduct Target Ther"},{"key":"7579_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fncel.2013.00162","volume":"7","author":"EM Dickins","year":"2013","unstructured":"Dickins EM, Salinas PC. Wnts in action: from synapse formation to synaptic maintenance. Front Cell Neurosci. 2013;7:162.","journal-title":"Front Cell Neurosci"},{"key":"7579_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.conb.2018.06.003","volume":"53","author":"F McLeod","year":"2018","unstructured":"McLeod F, Salinas PC. Wnt proteins as modulators of synaptic plasticity. Curr Opin Neurobiol. 2018;53:90\u20135.","journal-title":"Curr Opin Neurobiol"},{"key":"7579_CR42","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1523\/JNEUROSCI.1381-04.2004","volume":"24","author":"A Caricasole","year":"2004","unstructured":"Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A, et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer\u2019s brain. J Neurosci. 2004;24:6021\u20137.","journal-title":"J Neurosci"},{"key":"7579_CR43","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/27208","volume":"395","author":"Z Zhang","year":"1998","unstructured":"Zhang Z, Hartmann H, Do VM, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, et al. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 1998;395:698\u2013702.","journal-title":"Nature"},{"key":"7579_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fncel.2019.00295","volume":"13","author":"P Cisternas","year":"2019","unstructured":"Cisternas P, Oliva CA, Torres VI, Barrera DP, Inestrosa NC. Presymptomatic Treatment With Andrographolide improves brain metabolic markers and cognitive behavior in a model of early-onset Alzheimer\u2019s Disease. Front Cell Neurosci. 2019;13:295.","journal-title":"Front Cell Neurosci"},{"key":"7579_CR45","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/mp.2009.72","volume":"15","author":"EM Toledo","year":"2010","unstructured":"Toledo EM, Inestrosa NC. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe\/PSEN1DeltaE9 mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2010;15:272\u201385.","journal-title":"Mol Psychiatry"},{"key":"7579_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41419-022-04784-y","volume":"13","author":"XK Tong","year":"2022","unstructured":"Tong XK, Royea J, Hamel E. Simvastatin rescues memory and granule cell maturation through the Wnt\/\u03b2-catenin signaling pathway in a mouse model of Alzheimer\u2019s disease. Cell Death Dis. 2022;13:325.","journal-title":"Cell Death Dis"},{"key":"7579_CR47","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1242\/jcs.115.13.2771","volume":"115","author":"E Sadot","year":"2002","unstructured":"Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, et al. Regulation of S33\/S37 phosphorylated beta-catenin in normal and transformed cells. J Cell Sci. 2002;115:2771\u201380.","journal-title":"J Cell Sci"},{"key":"7579_CR48","doi-asserted-by":"publisher","first-page":"858782","DOI":"10.3389\/fonc.2022.858782","volume":"12","author":"K Shah","year":"2022","unstructured":"Shah K, Kazi JU. Phosphorylation-dependent regulation of WNT\/Beta-Catenin signaling. Front Oncol. 2022;12:858782.","journal-title":"Front Oncol"},{"key":"7579_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13195-019-0554-4","volume":"11","author":"L Poppe","year":"2019","unstructured":"Poppe L, Ru\u00e9 L, Timmers M, Lenaerts A, Storm A, Callaerts-Vegh Z, et al. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11:102.","journal-title":"Alzheimers Res Ther"},{"key":"7579_CR50","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1523\/JNEUROSCI.0722-17.2017","volume":"37","author":"SV Salazar","year":"2017","unstructured":"Salazar SV, Gallardo C, Kaufman AC, Herber CS, Haas LT, Robinson S, et al. Conditional deletion of Prnp rescues behavioral and synaptic deficits after disease onset in transgenic Alzheimer\u2019s Disease. J Neurosci. 2017;37:9207\u201321.","journal-title":"J Neurosci"},{"key":"7579_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nbd.2009.06.003","volume":"35","author":"XK Tong","year":"2009","unstructured":"Tong XK, Nicolakakis N, Fernandes P, Ongali B, Brouillette J, Quirion R, et al. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis. 2009;35:406\u201314.","journal-title":"Neurobiol Dis"},{"key":"7579_CR52","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1046\/j.1432-1327.2001.02197.x","volume":"268","author":"Y Kawamura","year":"2001","unstructured":"Kawamura Y, Kikuchi A, Takada R, Takada S, Sudoh S, Shibamoto S, et al. Inhibitory effect of a presenilin 1 mutation on the Wnt signalling pathway by enhancement of beta-catenin phosphorylation. Eur J Biochem. 2001;268:3036\u201341.","journal-title":"Eur J Biochem"},{"key":"7579_CR53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/mp.2010.9","volume":"15","author":"EM Toledo","year":"2010","unstructured":"Toledo EM, Inestrosa NC. Wnt signaling activation reduces neuropathological markers in a mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2010;15:228.","journal-title":"Mol Psychiatry"},{"key":"7579_CR54","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1007\/s12035-024-04462-4","volume":"62","author":"N Faraji","year":"2025","unstructured":"Faraji N, Ebadpour N, Abavisani M, Gorji A. Unlocking Hope: therapeutic advances and approaches in modulating the Wnt pathway for neurodegenerative diseases. Mol Neurobiol. 2025;62:3630\u201352.","journal-title":"Mol Neurobiol"},{"key":"7579_CR55","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.cub.2016.07.024","volume":"26","author":"A Marzo","year":"2016","unstructured":"Marzo A, Galli S, Lopes D, McLeod F, Podpolny M, Segovia-Roldan M, et al. Reversal of synapse degeneration by restoring Wnt signaling in the adult hippocampus. Curr Biol. 2016;26:2551\u201361.","journal-title":"Curr Biol"},{"key":"7579_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/dvdy.22065","volume":"239","author":"GG Far\u00edas","year":"2010","unstructured":"Far\u00edas GG, Godoy JA, Cerpa W, Varela-Nallar L, Inestrosa NC. Wnt signaling modulates pre- and postsynaptic maturation: therapeutic considerations. Dev Dyn. 2010;239:94\u2013101.","journal-title":"Dev Dyn"},{"key":"7579_CR57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jnc.14278","volume":"144","author":"C Tapia-Rojas","year":"2018","unstructured":"Tapia-Rojas C, Inestrosa NC. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer\u2019s disease in J20-APP transgenic and wild-type mice. J Neurochem. 2018;144:443\u201365.","journal-title":"J Neurochem"},{"key":"7579_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jnc.14608","volume":"149","author":"P Cisternas","year":"2019","unstructured":"Cisternas P, Zolezzi JM, Martinez M, Torres VI, Wong GW, Inestrosa NC. Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease. J Neurochem. 2019;149:54\u201372.","journal-title":"J Neurochem"},{"key":"7579_CR59","doi-asserted-by":"publisher","first-page":"e14382","DOI":"10.1371\/journal.pone.0014382","volume":"5","author":"A Fiorentini","year":"2010","unstructured":"Fiorentini A, Rosi MC, Grossi C, Luccarini I, Casamenti F. Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice. PLoS ONE. 2010;5:e14382.","journal-title":"PLoS ONE"},{"key":"7579_CR60","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","volume":"35","author":"D Wu","year":"2010","unstructured":"Wu D, Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci. 2010;35:161\u20138.","journal-title":"Trends Biochem Sci"},{"key":"7579_CR61","doi-asserted-by":"publisher","first-page":"721.","DOI":"10.3390\/cells10040721","volume":"10","author":"CL Sayas","year":"2021","unstructured":"Sayas CL, \u00c1vila J. GSK-3 and Tau: a key duet in Alzheimer\u2019s Disease. Cells. 2021;10:721.","journal-title":"Cells"},{"key":"7579_CR62","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neulet.2018.08.044","volume":"685","author":"N Zhang","year":"2018","unstructured":"Zhang N, Parr CJC, Birch AM, Goldfinger MH, Sastre M. The amyloid precursor protein binds to \u03b2-catenin and modulates its cellular distribution. Neurosci Lett. 2018;685:190\u20135.","journal-title":"Neurosci Lett"},{"key":"7579_CR63","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25:1680\u20133.","journal-title":"Nat Med"},{"key":"7579_CR64","doi-asserted-by":"publisher","first-page":"1373568","DOI":"10.3389\/fnmol.2024.1373568","volume":"17","author":"P Perez-Corredor","year":"2024","unstructured":"Perez-Corredor P, Vanderleest TE, Vacano GN, Sanchez JS, Villalba-Moreno ND, Marino C, et al. APOE3 Christchurch modulates \u03b2-catenin\/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer\u2019s cases. Front Mol Neurosci. 2024;17:1373568.","journal-title":"Front Mol Neurosci"},{"key":"7579_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72.","journal-title":"Mol Neurodegener"},{"key":"7579_CR66","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/tox.23541","volume":"37","author":"J Jiang","year":"2022","unstructured":"Jiang J, Cheng Y, Dai S, Zou B, Guo X. Suppression of rhomboid domain-containing 1 produces anticancer effects in pancreatic adenocarcinoma through affection of the AKT\/GSK-3\u03b2\/\u03b2-catenin pathway. Environ Toxicol. 2022;37:1944\u201356.","journal-title":"Environ Toxicol"},{"key":"7579_CR67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13046-018-0687-5","volume":"37","author":"M Zhang","year":"2018","unstructured":"Zhang M, Miao F, Huang R, Liu W, Zhao Y, Jiao T, et al. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1. J Exp Clin Cancer Res. 2018;37:22.","journal-title":"J Exp Clin Cancer Res"},{"key":"7579_CR68","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1007\/s12035-021-02544-1","volume":"58","author":"A Zab\u0142ocka","year":"2021","unstructured":"Zab\u0142ocka A, Kazana W, Sochocka M, Sta\u0144czykiewicz B, Janusz M, Leszek J, et al. Inverse correlation between Alzheimer\u2019s Disease and cancer: short overview. Mol Neurobiol. 2021;58:6335\u201349.","journal-title":"Mol Neurobiol"},{"key":"7579_CR69","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12264-018-0268-9","volume":"34","author":"JT Yang","year":"2018","unstructured":"Yang JT, Wang ZJ, Cai HY, Yuan L, Hu MM, Wu MN, et al. Sex differences in neuropathology and cognitive behavior in APP\/PS1\/tau Triple-Transgenic mouse model of Alzheimer\u2019s Disease. Neurosci Bull. 2018;34:736\u201346.","journal-title":"Neurosci Bull"},{"key":"7579_CR70","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1007\/s00018-021-03830-w","volume":"78","author":"D Zhu","year":"2021","unstructured":"Zhu D, Montagne A, Zhao Z. Alzheimer\u2019s pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci. 2021;78:4907\u201320.","journal-title":"Cell Mol Life Sci"},{"key":"7579_CR71","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/bjc.2011.107","volume":"104","author":"H Hong","year":"2011","unstructured":"Hong H, Nadesan P, Poon R, Alman BA. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). Br J Cancer. 2011;104:1452\u20138.","journal-title":"Br J Cancer"},{"key":"7579_CR72","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/en.2004-1649","volume":"147","author":"R Singh","year":"2006","unstructured":"Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology. 2006;147:141\u201354.","journal-title":"Endocrinology"},{"key":"7579_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/0018-506X(81)90013-1","volume":"15","author":"T Machida","year":"1981","unstructured":"Machida T, Yonezawa Y, Noumura T. Age-associated changes in plasma testosterone levels in male mice and their relation to social dominance or subordinance. Horm Behav. 1981;15:238\u201345.","journal-title":"Horm Behav"},{"key":"7579_CR74","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jamaneurol.2017.2807","volume":"74","author":"L Yu","year":"2017","unstructured":"Yu L, Dawe RJ, Boyle PA, Gaiteri C, Yang J, Buchman AS, et al. Association between brain gene expression, DNA methylation, and alteration of ex vivo magnetic resonance imaging transverse relaxation in late-life cognitive decline. JAMA Neurol. 2017;74:1473\u201380.","journal-title":"JAMA Neurol"},{"key":"7579_CR75","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012;9:628\u201345.","journal-title":"Curr Alzheimer Res"},{"key":"7579_CR76","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious orders study and rush memory and aging project. J Alzheimers Dis. 2018;64:S161\u2013s89.","journal-title":"J Alzheimers Dis"},{"key":"7579_CR77","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000096129","volume":"27","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, et al. Decision rules guiding the clinical diagnosis of Alzheimer\u2019s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006;27:169\u201376.","journal-title":"Neuroepidemiology"},{"key":"7579_CR78","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41746-023-00904-w","volume":"6","author":"S Tasaki","year":"2023","unstructured":"Tasaki S, Kim N, Truty T, Zhang A, Buchman AS, Lamar M, et al. Explainable deep learning approach for extracting cognitive features from hand-drawn images of intersecting pentagons. NPJ Digit Med. 2023;6:157.","journal-title":"NPJ Digit Med"},{"key":"7579_CR79","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.21706","volume":"66","author":"JA Schneider","year":"2009","unstructured":"Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009;66:200\u20138.","journal-title":"Ann Neurol"},{"key":"7579_CR80","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/brain\/aws234","volume":"135","author":"JA Schneider","year":"2012","unstructured":"Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012;135:3005\u201314.","journal-title":"Brain"},{"key":"7579_CR81","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1212\/01.WNL.0000042478.08543.F7","volume":"60","author":"DA Bennett","year":"2003","unstructured":"Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer\u2019s disease. Neurology. 2003;60:246\u201352.","journal-title":"Neurology"},{"key":"7579_CR82","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ana.25380","volume":"85","author":"PA Boyle","year":"2019","unstructured":"Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, et al. Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies. Ann Neurol. 2019;85:114\u201324.","journal-title":"Ann Neurol"},{"key":"7579_CR83","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bcp.2014.01.037","volume":"88","author":"DA Bennett","year":"2014","unstructured":"Bennett DA, Yu L, De Jager PL. Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer\u2019s disease. Biochem Pharm. 2014;88:617\u201330.","journal-title":"Biochem Pharm"},{"key":"7579_CR84","doi-asserted-by":"publisher","first-page":"e1002287","DOI":"10.1371\/journal.pmed.1002287","volume":"14","author":"CC White","year":"2017","unstructured":"White CC, Yang HS, Yu L, Chibnik LB, Dawe RJ, Yang J, et al. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017;14:e1002287.","journal-title":"PLoS Med"},{"key":"7579_CR85","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/j.1471-4159.2005.03135.x","volume":"93","author":"S Peng","year":"2005","unstructured":"Peng S, Wuu J, Mufson EJ, Fahnestock M. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer\u2019s disease. J Neurochem. 2005;93:1412\u201321.","journal-title":"J Neurochem"},{"key":"7579_CR86","doi-asserted-by":"publisher","first-page":"e72457","DOI":"10.1371\/journal.pone.0072457","volume":"8","author":"SL Eaton","year":"2013","unstructured":"Eaton SL, Roche SL, Llavero Hurtado M, Oldknow KJ, Farquharson C, Gillingwater TH, et al. Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS ONE. 2013;8:e72457.","journal-title":"PLoS ONE"},{"key":"7579_CR87","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.tibs.2018.11.010","volume":"44","author":"S Varland","year":"2019","unstructured":"Varland S, Vandekerckhove J, Drazic A. Actin post-translational modifications: the Cinderella of cytoskeletal control. Trends Biochem Sci. 2019;44:502\u201316.","journal-title":"Trends Biochem Sci"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07579-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:13:35Z","timestamp":1744478015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07579-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7579"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07579-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.22.579698","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in compliance with relevant guidelines and regulations. All animal procedures were approved by McGill\u2019s Animal Care Committee (Animal Use Protocol # MCGL-7868) and performed in accordance with the ARRIVE guidelines. The human data used in this study were obtained from the Religious Orders Study and the ROSMAP study, approved by the Institutional Review Board of Rush University Medical Center, as well as from the Center for Brain Aging & Dementia Tissue Repository at University of California, Irvine. Each participant provided informed consent, including an Anatomic Gift Act and repository consent, to allow their data to be repurposed for research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"280"}}